AI-based Self-Insight Treatment Tool (SITT): pre and post-effectiveness testing on adult patients with depression, anxiety, PTSD, OCD

Objective: This research evaluates how well the AI-Based Self-Insight Treatment Tool (SITT) functions when treating adults with depression and anxiety and patients with PTSD and OCD. Methodology: The research adopted a pre-post intervention approach spanning from May 2022 to May 2023, involving 84 participants who had depression (25) or anxiety (35) or PTSD (17), or OCD (7). SITT functions as the only intervention through its non-verbal AI-driven tool. Results: The participants’ heart rates decreased significantly through all test conditions (depression: 88.93 bpm to 67.66 bpm; PTSD: 86.34 bpm to 68.38 bpm) alongside substantial increases in participant self-evaluation scores for life satisfaction and restfulness (depression: 30.9 to 85.42; anxiety: 40.32 to 83.74). SITT provides therapy through minimal human intervention (2–25%) while using a non-verbal approach that respects cultural sensitivity, which indicates its ability to address traditional therapy obstacles like stigma and resource limitations. Conclusion: The study results demonstrate that SITT represents an affordable and expandable solution for mental healthcare because its AI-powered biofeedback system works with specific therapeutic sections to produce meaningful therapeutic results.